We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.25B
AUM Growth
+$136M
Cap. Flow
+$60.6M
Cap. Flow %
4.87%
Top 10 Hldgs %
22.84%
Holding
2,021
New
430
Increased
368
Reduced
444
Closed
703

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$28M
2
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
+$19.2M
3
MON
Monsanto Co
MON
+$12.5M
4
COL
Rockwell Collins
COL
+$10.9M
5
AAAP
Advanced Accelerator Applications S.A.
AAAP
+$9.71M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$30M
2
PRXL
Parexel International Corp
PRXL
+$17.6M
3
LVLT
Level 3 Communications Inc
LVLT
+$14.6M
4
ALR
Alere Inc
ALR
+$13.8M
5
KITE
Kite Pharma, Inc.
KITE
+$8.05M

Sector Composition

Rank Sector Weight
1 Technology 16.16%
2 Communication Services 12.62%
3 Healthcare 9.79%
4 Consumer Discretionary 7.25%
5 Industrials 4.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AN icon
1326
AutoNation
AN
$7.13B
– –
-750
Closed -$36K
ANIK icon
1327
CALL
Anika Therapeutics
ANIK
$262M
– –
-25,700
Closed -$1.49M
AORT icon
1328
Artivion
AORT
$1.31B
– –
-9,509
Closed -$216K
AOS icon
1329
A.O. Smith
AOS
$8.61B
– –
-68
Closed -$4K
APTV icon
1330
Aptiv
APTV
$10.1B
– –
-532
Closed -$52K
ARAY icon
1331
Accuray
ARAY
$37.2M
– –
-8,205
Closed -$33K
ARCT icon
1332
Arcturus Therapeutics
ARCT
$177M
– –
-1,171
Closed -$8K
ARCO icon
1333
Arcos Dorados Holdings
ARCO
$1.76B
– –
-1,336
Closed -$13K
AROC icon
1334
Archrock
AROC
$6.26B
– –
-8,200
Closed -$103K
ARWR icon
1335
Arrowhead Research
ARWR
$12.6B
– –
-600
Closed -$3K
ASMB icon
1336
Assembly Biosciences
ASMB
$524M
– –
-83
Closed -$35K
ASPS icon
1337
Altisource Portfolio Solutions
ASPS
$60M
– –
-38
Closed -$8K
ASTE icon
1338
Astec Industries
ASTE
$1.2B
– –
-2,300
Closed -$129K
ATI icon
1339
PUT
ATI
ATI
$27.3B
– –
-1,000
Closed -$24K
ATRA icon
1340
Atara Biotherapeutics
ATRA
$79M
– –
-529
Closed -$219K
ATRO icon
1341
Astronics
ATRO
$3.73B
– –
-4,346
Closed -$94K
AVB icon
1342
AvalonBay Communities
AVB
$27B
– –
-159
Closed -$28K
AVDL
1343
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-6,900
Closed -$72K
BAH icon
1344
Booz Allen Hamilton
BAH
$8.85B
– –
-5,600
Closed -$209K
BANF icon
1345
BancFirst
BANF
$3.85B
– –
-100
Closed -$6K
BBGI icon
1346
Beasley Broadcasting Group
BBGI
$47.1M
– –
-135
Closed -$31K
BBWI icon
1347
Bath & Body Works
BBWI
$4.24B
– –
-7,796
Closed -$262K
BC icon
1348
Brunswick
BC
$5.41B
– –
-6,270
Closed -$351K
BCC icon
1349
Boise Cascade
BCC
$3.04B
– –
-600
Closed -$21K
BDN
1350
Brandywine Realty Trust
BDN
$546M
– –
-14,393
Closed -$252K
52 53
54
55 56

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
WGAM
Wilkinson Global Asset Management New York $1.31B AUM 17.03% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return

Prelude Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Prelude Capital Management held 2,021 positions worth $1.25B, up 12% from $1.11B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Prelude Capital Management deployed $60.6M of net new capital in Q4 2017, opening 430 new positions and adding to 368 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 328,795 shares worth $11.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Western Digital, an estimated $7.02M trimmed.

  • Prelude Capital Management's largest Q4 2017 buy was Twenty-First Century Fox, Inc. Class B: 328,795 shares worth $11.2M.
  • Prelude Capital Management added most to NXP Semiconductors in Q4 2017, an estimated $28M increase.
  • Prelude Capital Management's biggest Q4 2017 reduction was Western Digital, cutting an estimated $7.02M.
  • Prelude Capital Management fully exited CR Bard Inc. in Q4 2017, selling an estimated $30M.
  • Prelude Capital Management's ten largest holdings make up 23% of its $1.25B portfolio in Q4 2017.
  • Prelude Capital Management opened 430 new positions and closed 703 in Q4 2017.
  • Prelude Capital Management's portfolio value rose 12% quarter-over-quarter to $1.25B.

Based on Prelude Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.